Year All20252024202320222021202020192018201720162015201420122011 May 8, 2018 Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights Mar 19, 2018 Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada Mar 14, 2018 Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors Feb 12, 2018 Ardelyx Announces Departure of Chief Scientific Officer Feb 8, 2018 Ardelyx to Participate in Leerink Partners 7th Annual Global Healthcare Conference Jan 3, 2018 Ardelyx Announces Presentation at J.P. Morgan 36th Annual Healthcare Conference Jan 3, 2018 Ardelyx Successfully Completes T3MPO-3 Safety Extension Study of Tenapanor for IBS-C Dec 11, 2017 Ardelyx Announces License Agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China Nov 28, 2017 Ardelyx and Kyowa Hakko Kirin Announce License Agreement for Tenapanor for Cardiorenal Diseases in Japan Nov 21, 2017 Ardelyx Announces Updated Development Path for its Cardiorenal Pipeline